These questions and answers (Q&As) are based on the most recent interim recommendations from the WHO Strategic Advisory Group of Experts on Immunization (SAGE) for COVID-19 vaccines that have been approved by WHO under Emergency Use Listing (EUL) as of 15 February 2022:
- Pfizer–BioNTech BNT162b2
- Moderna mRNA-1273
- AstraZeneca AZD1222 VaxzevriaTM, SII COVISHIELDTM ChAdOx1-S [recombinant]
- Janssen Ad26.COV2.S
- Sinopharm BIBP
- Sinovac–CoronaVac
- Bharat Biotech BBV152 COVAXIN®
- Novavax NVX-Co2373
The Q&As are intended to provide answers to health providers and the public on COVID-19 vaccination during pregnancy. Q&As related to COVID-19 vaccines and breastfeeding can be found at the following link: FREQUENTLY ASKED QUESTIONS: COVID-19 vaccines and breastfeeding based on WHO interim recommendations.